Health Condition 1: null- Differentiated Thyroid Cancer
Conditions
Interventions
Intervention1: Radioiodine 25 mci: single dose, injectible
Intervention2: Radioiodine,50 mci: single dose, injectible
Control Intervention1: Radioiodine 100mci: 100 mCi single dose, injectible
Sponsors
All India Institute of Medical Sciences
Indian Council of Medical Research
Eligibility
Inclusion criteria
Inclusion criteria: Patients with disease confirmed to be limited to the thyroid bed only by clinical, radiological, per-operative, and post-surgical 131I scintigraphic examination and having no evidence of extra thyroidal or distant metastases at the time of radioiodine treatment. Patients with tumor size (T1-3)
Exclusion criteria
Exclusion criteria: Patients with less than total/near total thyroidectomy. T4 tumor size. Aggressive histology such as tall cell and columnar cell papillary carcinoma, hurthle cell carcinoma and poorly differentiated carcinoma. If at any time, extra thyroidal disease in the form of either nodal or distant metastases was detected before the first-dose outcome. Pregnant and breast-feeding patients. Patient who were otherwise fulfilling all criteria of inclusion, but did not give consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Remnant AblationTimepoint: Six months followed by first dose of Radioiodine | — |
Secondary
| Measure | Time frame |
|---|---|
| NoneTimepoint: None | — |
Countries
India
Contacts
Public ContactDr C S Bal
All India Institute of Medical Sciences (AIIMS)
Outcome results
None listed